ArticleBMC cardiovascular disorders2026
Joint assessment of frailty index and metabolic syndrome score for cardiovascular disease in middle aged and older Chinese adults: insights from a national cohort study 2011-2020.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundBoth frailty and metabolic syndrome (Met) frequently coexist in older adults, creating a complex syndemic that possibly amplifies cardiovascular disease (CVD) risks. This study aims to evaluate whether frailty and metabolic syndrome severity have a synergistic impact on the risk of cardiovascular events among middle-aged and older cohorts in China.
methodWe analyzed data from China Health and Retirement Longitudinal Study (CHARLS) 2011-2020 of 8,992 individuals. The associations of frailty (as represented by frailty index) and metabolic syndrome severity (as represented by metabolic syndrome score) with CVD risks were examined using Cox regression and restricted cubic splines. The predictive performance was assessed by receiver operating characteristic (ROC) curve analysis. Furthermore, potential mediating factors were investigated through mediation analysis.
resultIndividuals with high frailty index (FI) and high metabolic syndrome score (MetS) (FI > 4.36 and MetS > 0.17) were at the highest CVD risk (HR = 1.295, 95% CI: 1.141-1.469), suggesting a synergistic association. High FI significantly mediated 10.8% of the association between the Met and CVD risk. Next, we established FI-MetS by multiplying the two indicators, which was independently associated with an increased risk of CVD (HR = 1.011 per 1-point increment, 95% CI 1.006-1.015). It showed a positive linear relationship with CVD risk. The predictive value of FI-MetS was greater than FI alone and MetS alone.
conclusionGiven its significant predictive capability regarding cardiovascular disease development in older Chinese cohorts, FI-MetS should be adopted as a primary tool for risk screening, superseding the use of separate frailty or metabolic syndrome assessments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.